Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 17 min 50 sec ago

The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board

Mon, 08/31/2015 - 14:10
PARSIPPANY, N.J.--(Healthcare Sales & Marketing Network)--The Medicines Company (MDCO) today announced that its Board of Directors has named Dr. Fred Eshelman, founder of Eshelman Ventures LLC, an investment company focused on healthcare companies, as non-...
Biopharmaceuticals, Personnel
The Medicines Company

FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

Mon, 08/31/2015 - 14:02
NEW YORK, Aug. 31, 2015 -- (Healthcare Sales & Marketing Network) -- Intercept Pharmaceuticals, Inc. (ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic unde...
Biopharmaceuticals, FDA
Intercept Pharmaceuticals, obeticholic acid, cirrhosis

Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction

Fri, 08/28/2015 - 15:14
Offer Substantially Undervalues Perrigo, Exposes Shareholders to Risk and Mylan's Weak Business Prospects Value Destructive Transaction Would Be Highly Dilutive to EPS and Perrigo's Growth and P/E Multiple Perrigo Positioned to Create Superior Value ...
Biopharmaceuticals, Mergers & Acquisitions
Perrigo Company, Mylan

Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo

Fri, 08/28/2015 - 15:12
Mylan Intends to Launch Formal Offer to Perrigo Shareholders in the Coming Weeks HERTFORDSHIRE, England and PITTSBURGH, Aug. 28, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (MYL) today announced that its shareholders have approved Myla...
Biopharmaceuticals, Mergers & Acquisitions
Mylan, Perrigo Company

Symmetry Surgical Acquires Vesocclude Medical

Fri, 08/28/2015 - 15:09
First step in acquisition strategy expands proprietary product portfolio and sales network $4.0 million purchase price for $3.2 million Last Twelve Months Proforma revenue and $0.5 million Proforma EBITDA Purchase price funded from existing cash rese...
Devices, Surgery, Mergers & Acquisitions
Symmetry Surgical, Vesocclude Medical

Therapy System for Treating Major Depressive Disorder Receives FDA Clearance

Fri, 08/28/2015 - 14:27
MagVenture's MagVita TMS Therapy System® receives FDA clearance to be marketed as a medical device for the delivery of repetitive Transcranial Magnetic Stimulation (TMS) as a treatment for Major Depressive Disorder LOS ANGELES, FARUM, Denmark and AT...
Devices, Neurology, FDA
MagVenture, MagVita TMS, Major Depressive Disorder

Hospira Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet

Thu, 08/27/2015 - 15:52
Next-generation infusion system offers expanded drug library and EMR interoperability LAKE FOREST, Ill., Aug. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Hospira, Inc. (HSP), the world's leading provider of injectable drugs and infusion techn...
Devices, Drug Delivery, Product Launch
Hospira, Hospira MedNet, Plum 360 Infusion System, infusion pump

InSite Vision and QLT Amend Merger Agreement

Thu, 08/27/2015 - 15:45
InSite Board Determines Previously Announced Unsolicited Binding Offer from a Multi-National Pharmaceutical Company No Longer Constitutes a “Company Superior Proposal” ALAMEDA, Calif.--(Healthcare Sales & Marketing Network)--InSite Vision Inc. (INSV) to...
Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions
InSite Vision, QLT, DuraSite, AzaSite, azithromycin

Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer

Thu, 08/27/2015 - 14:25
Experienced Oncology Leader To Spearhead Clinical Development Of CytomX Probody™ Therapeutic Pipeline SOUTH SAN FRANCISCO, Calif., Aug. 27, 2015 -- (Healthcare Sales & Marketing Network) -- CytomX Therapeutics, Inc., a biopharmaceutical company develop...
Biopharmaceuticals, Personnel
CytomX Therapeutics, Probody

Greatbatch Signs Definitive Agreement to Acquire Lake Region Medical for $1.73 Billion

Thu, 08/27/2015 - 14:19
Transformative Deal will create one of the World's Largest Medical Device OEM Suppliers and will be led by current Greatbatch President and CEO, Thomas J. Hook Newly Combined Company to offer substantially more Comprehensive Portfolio for Customers D...
Devices, Mergers & Acquisitions
Greatbatch, Lake Region Medical

ECM Medical Signs Agreement with Vertebral Technologies to Distribute Innovative Modular Spinal Implants for Greater China

Wed, 08/26/2015 - 15:14
MINNEAPOLIS and BEIJING, Aug. 26, 2015 -- (Healthcare Sales & Marketing Network) -- ECM Medical (ECM), a China-focused medical device company, announces the acquisition of Greater China distribution rights for the Interfuse™ System of novel spinal implant...
Devices, Orthopaedic, Neurosurgery, Distribution
ECM Medical, Vertebral Technologies, Interfuse, spinal implant

Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer

Wed, 08/26/2015 - 15:10
PRINCETON, N.J.--(Healthcare Sales & Marketing Network)--Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice President, Finance and Chief Financial Officer. H...
Biopharmaceuticals, Personnel
Adare Pharmaceuticals

Providence Medical Technology Announces New Financing of $12 Million

Wed, 08/26/2015 - 15:08
Company Also Announces Appointment of Jason Hoffman as Vice President of Global Sales LAFAYETTE, Calif.--(Healthcare Sales & Marketing Network)--Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announc...
Devices, Orthopaedic, Neurosurgery, Venture Capital
Providence Medical Technology, DTRAX, spinal implant

Alvogen to Acquire Product Portfolio from Pfizer for the U.S. Market

Wed, 08/26/2015 - 15:03
PINE BROOK, N.J.--(Healthcare Sales & Marketing Network)--Alvogen has entered into a definitive agreement with Pfizer Inc. (PFE), under which it will acquire a portfolio of four pharmaceutical products, in the U.S. Alvogen has developed a strong track r...
Biopharmaceuticals, Acquisitions
Alvogen, Pfizer, Clindamycin, Acetylcysteine, Voriconazole, Melphalan

FDA Approves Dexcom G5(R) Mobile Continuous Glucose Monitoring System

Tue, 08/25/2015 - 21:42
First and Only Fully Mobile CGM System Allows Adults and Children as young as 2 years old to Conveniently and Discreetly Monitor and Share Glucose Levels SAN DIEGO--(Healthcare Sales & Marketing Network)-- Dexcom, Inc., (DXCM), a leader in continuous gl...
Devices, Monitoring, Endocrinology, FDA
Dexcom, glucose monitor, G5 Mobile CGM

EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter

Tue, 08/25/2015 - 18:55
FDA De Novo 510(k) Review of Prostatic Tissue Ablation Device to Resume LYON, France, Aug. 25, 2015 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced that on Friday August 21, 2...
Devices, Oncology, FDA
EDAP TMS, Ablatherm, HIFU, prostate cancer

Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development

Tue, 08/25/2015 - 18:48
LA JOLLA, Calif., Aug. 25, 2015 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appoin...
Biopharmaceuticals, Personnel
Regulus Therapeutics, microRNA

Xtant Medical Announces FDA Approval of OsteoSelect(R) PLUS

Tue, 08/25/2015 - 15:05
BELGRADE, Mont., Aug. 25, 2015 -- (Healthcare Sales & Marketing Network) -- Xtant Medical Holdings, Inc. (BONE), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, Bacterin I...
Devices, Regenerative Medicine, Orthopaedic, FDA
Xtant Medical, OsteoSelect PLUS, Demineralized Bone Matrix

Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners

Tue, 08/25/2015 - 14:58
Transaction Expands Panther's Capital Base to Negotiate New Product Opportunities and Finance Existing Asset Advancement CHICAGO, IL and LA JOLLA, CA--(Healthcare Sales & Marketing Network) - Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology...
Biopharmaceuticals, Venture Capital
Panther Biotechnology, transferrin glycoprotein, TRF-DOX

Upsher-Smith Laboratories Names Rusty Field President

Mon, 08/24/2015 - 15:39
MAPLE GROVE, Minn., Aug. 24, 2015 -- (Healthcare Sales & Marketing Network) -- Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that its Chief Commercial Officer, Rusty Field, has been named President of the company. Mr. Field brings with hi...
Biopharmaceuticals, Personnel
Upsher-Smith Laboratories

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong